ARTICLE | Company News
Apexigen Inc., Gansu Duyiwei deal
March 12, 2012 7:00 AM UTC
Apexigen granted Gansu Duyiwei's Shanghai Duyiwei Biotechnology Co. Ltd. subsidiary an exclusive license to develop and commercialize APX004 in China. The humanized mAb against VEGF receptor 2 ( KDR/...